NCT03053947View on ClinicalTrials.gov

Pain Free Laceration Repairs Using Intra-nasal Ketamine

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 16, 2017

Primary Completion Date

November 27, 2019

Study Completion Date

November 27, 2019

Conditions
Laceration
Interventions
DRUG

Intranasal Ketamine

Administration of intranasal ketamine at a dose from 3 to 9 mg/kg for safe and effective procedural sedation for laceration repair in the ED for children aged 1 to 12 year-old.

Trial Locations (2)

M5G 1X8

Sickkids, Toronto

H3T 1C5

St. Justine's Hospital, Montreal

All Listed Sponsors
lead

Evelyne D.Trottier

OTHER

NCT03053947 - Pain Free Laceration Repairs Using Intra-nasal Ketamine | Biotech Hunter | Biotech Hunter